Equity Research, Broker Reports, and media content on Abivax

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Abivax
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Abivax. We currently have 7 research reports from 1 professional analysts.

Open
N/A
Range Today
N/A
52 Week
540/2540c
Daily Volume
N/A
# Shares
0m
Daily Liquidity
0.0%
Pension Liability
Enterprise Value
n/am
Market Cap
83.0m
Latest PE (hist)
Div Yield
Date Source Announcement
25Jun19 15:16 EQS Abivax SA (ABVX-FR): Ready to deal with inflammation
11Mar19 14:54 EQS Abivax SA (ABVX-FR): ABX464: sustained safety and benefit in inflammatory bowel
22Jan19 14:58 EQS Abivax SA (ABVX-FR): Getting a brake in inflammation
06Sep18 10:16 EQS Abivax SA (ABVX-FR): Remarkable data opens door to $15bn IBD market
04Jul18 11:34 EQS Abivax SA (ABVX-FR): ABX464 reduces HIV DNA in latent viral gut reservoir
  • Frequency of research reports

     

  • Research reports on

    Abivax

  • Providers covering

    Abivax